{"id":2791,"date":"2025-10-09T13:01:20","date_gmt":"2025-10-09T13:01:20","guid":{"rendered":"https:\/\/drbelalbinasaf.com\/blog\/?p=2791"},"modified":"2025-10-09T13:12:26","modified_gmt":"2025-10-09T13:12:26","slug":"biomarkers-in-lung-cancer","status":"publish","type":"post","link":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/","title":{"rendered":"Biomarkers in Lung Cancer: Unlocking Precision Treatment"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Lung cancer remains one of the most common and deadliest malignancies worldwide. Early detection and accurate molecular characterization are critical for improving survival. One of the most transformative advances in recent years is the integration of biomarker testing\u2014the identification of measurable biological indicators that reveal a tumor\u2019s molecular profile, behavior, and treatment vulnerabilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In modern thoracic oncology, biomarkers guide not only diagnosis and prognosis, but most importantly, the selection of targeted therapies and immunotherapies that have dramatically improved outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Are Biomarkers and Why Do They Matter in Lung Cancer?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Biomarkers are biological molecules\u2014such as DNA, RNA, proteins, or metabolites\u2014found in tissue, blood, or other body fluids that signal normal or abnormal processes. In lung cancer, they can help:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Detect cancer earlier, even before symptoms appear<\/li>\n\n\n\n<li>Distinguish between different cancer subtypes (e.g., NSCLC vs. SCLC)<\/li>\n\n\n\n<li>Predict how a patient will respond to a specific drug<\/li>\n\n\n\n<li>Monitor treatment response or disease recurrence<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Molecular testing has made personalized medicine a reality in lung cancer\u2014ensuring each patient receives therapy tailored to the genetic and immunologic makeup of their tumor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Key Genetic and Molecular Biomarkers in Non-Small Cell Lung Cancer (NSCLC)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most biomarker testing is performed in NSCLC, particularly in adenocarcinoma and never-smoker patients, though squamous histology is also being increasingly profiled when feasible.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Actionable Genetic Alterations (Driver Mutations and Fusions):<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Biomarker<\/strong><\/td><td><strong>Molecular Type<\/strong><\/td><td><strong>Key Notes<\/strong><\/td><td><strong>Targeted Therapy<\/strong><\/td><\/tr><tr><td><strong>EGFR mutations<\/strong><\/td><td>Point mutations\/exon 19 deletions\/exon 21 L858R<\/td><td>Common in non-smokers; exon 20 insertions have distinct therapies<\/td><td>Osimertinib, Amivantamab (for exon 20ins)<\/td><\/tr><tr><td><strong>ALK rearrangements<\/strong><\/td><td>Gene fusion<\/td><td>Younger non-smokers; sensitive to ALK inhibitors<\/td><td>Alectinib, Lorlatinib<\/td><\/tr><tr><td><strong>ROS1 fusions<\/strong><\/td><td>Gene fusion<\/td><td>~1\u20132% NSCLC<\/td><td>Entrectinib, Crizotinib<\/td><\/tr><tr><td><strong>BRAF V600E<\/strong><\/td><td>Point mutation<\/td><td>~2% NSCLC<\/td><td>Dabrafenib + Trametinib<\/td><\/tr><tr><td><strong>MET exon 14 skipping<\/strong><\/td><td>Splicing alteration<\/td><td>~3\u20134% NSCLC<\/td><td>Capmatinib, Tepotinib<\/td><\/tr><tr><td><strong>RET fusions<\/strong><\/td><td>Gene fusion<\/td><td>&lt;2% NSCLC<\/td><td>Selpercatinib, Pralsetinib<\/td><\/tr><tr><td><strong>NTRK fusions<\/strong><\/td><td>Gene fusion<\/td><td>&lt;1% but pan-cancer actionable<\/td><td>Entrectinib, Larotrectinib<\/td><\/tr><tr><td><strong>KRAS G12C<\/strong><\/td><td>Point mutation<\/td><td>Most common (~25\u201330%); smoking-related<\/td><td>Sotorasib, Adagrasib<\/td><\/tr><tr><td><strong>HER2 mutations<\/strong><\/td><td>Exon 20 insertions<\/td><td>2\u20134% of NSCLC<\/td><td>Trastuzumab Deruxtecan (T-DXd)<\/td><\/tr><tr><td><strong>NRG1 fusions<\/strong><\/td><td>Rare fusion<\/td><td>Under clinical evaluation<\/td><td>Experimental therapies (Afatinib, Seribantumab trials)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Testing methods: Next-Generation Sequencing (NGS) is now the preferred standard, as recommended by NCCN, ESMO, and CAP\/IASLC\/AMP guidelines, due to its ability to detect multiple actionable alterations simultaneously using minimal tissue.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">PD-L1 Expression and Immunotherapy Response<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">PD-L1 (Programmed Death-Ligand 1) is a key immunohistochemical biomarker that helps predict response to immune checkpoint inhibitors (ICIs) such as pembrolizumab, nivolumab, or atezolizumab.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>PD-L1 expression is quantified using Immunohistochemistry (IHC) and reported as a Tumor Proportion Score (TPS).<\/li>\n\n\n\n<li>Patients with TPS \u226550% are often eligible for first-line single-agent immunotherapy.<\/li>\n\n\n\n<li>Even patients with lower PD-L1 expression (1\u201349%) may benefit from chemo-immunotherapy combinations.<\/li>\n\n\n\n<li>Absence of PD-L1 expression (TPS &lt;1%) does not exclude immunotherapy but may influence regimen choice.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Protein Biomarkers Used in Clinical Practice<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Although tissue and molecular tests are the gold standard, serum protein biomarkers continue to play a role in disease monitoring, especially when tissue sampling is difficult. They have a very limited role in the management of Lung Cancer.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Biomarker<\/strong><\/td><td><strong>Associated Subtype<\/strong><\/td><td><strong>Clinical Use<\/strong><\/td><\/tr><tr><td><strong>CEA (Carcinoembryonic Antigen)<\/strong><\/td><td>Adenocarcinoma<\/td><td>Treatment response and recurrence monitoring<\/td><\/tr><tr><td><strong>CYFRA 21-1<\/strong><\/td><td>Squamous cell carcinoma<\/td><td>Disease monitoring; higher baseline levels correlate with poorer prognosis<\/td><\/tr><tr><td><strong>SCC Antigen<\/strong><\/td><td>Squamous carcinoma<\/td><td>Adjunctive diagnostic marker<\/td><\/tr><tr><td><strong>NSE (Neuron-Specific Enolase)<\/strong><\/td><td>Small Cell Lung Cancer (SCLC)<\/td><td>Disease activity monitoring<\/td><\/tr><tr><td><strong>Pro-GRP (Progastrin-Releasing Peptide)<\/strong><\/td><td>SCLC<\/td><td>Highly specific, often superior to NSE for diagnosis and follow-up<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">These markers are not diagnostic in isolation but provide valuable complementary data with imaging and histopathology.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Emerging Biomarkers: Liquid Biopsy and Circulating microRNAs<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Liquid biopsy\u2014testing circulating tumor DNA (ctDNA) or microRNAs (miRNAs) from plasma\u2014is transforming the landscape of lung cancer diagnostics.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ctDNA NGS can detect resistance mutations (e.g., EGFR T790M or C797S) non-invasively.<\/li>\n\n\n\n<li>Circulating microRNAs (c-miRNAs) such as miR-21, miR-155, and miR-210 show potential as early detection and prognostic tools, though they remain research-stage rather than clinical routine.<\/li>\n\n\n\n<li>Liquid biopsy is particularly useful when tissue biopsy is not feasible or for monitoring minimal residual disease (MRD).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Personalized Treatment Through Biomarker-Driven Medicine<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Biomarker integration allows clinicians to design customized treatment pathways:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Targeted Therapy:<\/strong> For tumors harboring actionable mutations (EGFR, ALK, ROS1, etc.).<\/li>\n\n\n\n<li><strong>Immunotherapy:<\/strong> For tumors with PD-L1 expression or high Tumor Mutational Burden (TMB).<\/li>\n\n\n\n<li><strong>Combination or Sequential Strategies:<\/strong> Guided by evolving biomarker profiles on re-biopsy or liquid biopsy.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This approach minimizes ineffective therapy exposure, reduces toxicity, and improves progression-free and overall survival.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Biomarkers have revolutionized the way we understand and treat lung cancer. From driver mutation detection to immune profiling and liquid biopsies, these molecular insights enable oncologists to move from a \u201cone-size-fits-all\u201d approach to precision oncology.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As research progresses, novel biomarkers\u2014such as MET amplifications, KRAS co-mutations, TMB, and microRNA signatures\u2014are expected to further refine therapy selection and prognostication.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you or a loved one is diagnosed with lung cancer, discuss comprehensive biomarker testing with your oncologist or pathologist\u2014it could define the most effective, personalized treatment strategy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions (FAQ)<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Q1: Are biomarkers enough to diagnose lung cancer?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A:<\/strong> No. Biomarkers supplement, but do not replace, histopathological diagnosis based on tissue morphology.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Q2: When should biomarker testing be done?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A:<\/strong> Ideally at the time of initial diagnosis of NSCLC, particularly in advanced (stage III\u2013IV) disease, before treatment initiation. Retesting may be indicated at progression.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Q3: Can biomarker profiles change over time?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A:<\/strong> Yes. Tumor heterogeneity and treatment pressure can lead to new resistance mutations; hence, repeat testing (tissue or liquid biopsy) may be necessary.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Q4: How are biomarkers tested?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A:<\/strong> Via tissue biopsy, blood-based assays, or pleural fluid samples using methods like NGS, PCR, or IHC.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Q5: Are biomarker tests accessible to all patients?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A:<\/strong> Most major cancer centers and tertiary hospitals offer biomarker testing. In India, government and private panels (e.g., FoundationOne CDx, OncoFocus) are increasingly available.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Q6: Are they expensive?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A<\/strong>: Costs have decreased substantially; guideline-recommended biomarker panels are often covered under insurance or institutional cancer care programs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lung cancer remains one of the most common and deadliest malignancies worldwide. Early detection and accurate molecular characterization are critical [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2794,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-2791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lung-cancer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biomarkers in Lung Cancer: Unlocking Precision Treatment<\/title>\n<meta name=\"description\" content=\"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarkers in Lung Cancer: Unlocking Precision Treatment\" \/>\n<meta property=\"og:description\" content=\"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Dr. Belal Bin Asaf\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/Dr.BelalBinAsaf\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-09T13:01:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T13:12:26+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/localhost\/bilal\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Belal Bin Asaf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DrBelalBinAsaf\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Belal Bin Asaf\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\"},\"author\":{\"name\":\"Dr. Belal Bin Asaf\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/person\/f25b0c54277f74ec9c5f47d5800ac337\"},\"headline\":\"Biomarkers in Lung Cancer: Unlocking Precision Treatment\",\"datePublished\":\"2025-10-09T13:01:20+00:00\",\"dateModified\":\"2025-10-09T13:12:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\"},\"wordCount\":980,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp\",\"articleSection\":[\"Lung Cancer\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\",\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\",\"name\":\"Biomarkers in Lung Cancer: Unlocking Precision Treatment\",\"isPartOf\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp\",\"datePublished\":\"2025-10-09T13:01:20+00:00\",\"dateModified\":\"2025-10-09T13:12:26+00:00\",\"description\":\"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.\",\"breadcrumb\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage\",\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp\",\"contentUrl\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp\",\"width\":1200,\"height\":630,\"caption\":\"Biomarkers in Lung Cancer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/drbelalbinasaf.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomarkers in Lung Cancer: Unlocking Precision Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#website\",\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/\",\"name\":\"Dr. Belal Bin Asaf\",\"description\":\"Blog\",\"publisher\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/drbelalbinasaf.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#organization\",\"name\":\"Dr. Belal Bin Asaf\",\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/06\/dr-belal-bin-asaf-chest-surgeon.svg\",\"contentUrl\":\"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/06\/dr-belal-bin-asaf-chest-surgeon.svg\",\"caption\":\"Dr. Belal Bin Asaf\"},\"image\":{\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/person\/f25b0c54277f74ec9c5f47d5800ac337\",\"name\":\"Dr. Belal Bin Asaf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g\",\"caption\":\"Dr. Belal Bin Asaf\"},\"sameAs\":[\"https:\/\/drbelalbinasaf.com\/blog\",\"https:\/\/www.facebook.com\/Dr.BelalBinAsaf\/\",\"https:\/\/www.instagram.com\/DrBelalBinAsaf\/\",\"https:\/\/www.linkedin.com\/in\/dr-belal-bin-asaf-34682223\/\",\"https:\/\/x.com\/DrBelalBinAsaf\",\"https:\/\/www.youtube.com\/channel\/UCl5MoT9A1VxaVXT4lRnuc2w\"],\"url\":\"https:\/\/drbelalbinasaf.com\/blog\/author\/dr_admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarkers in Lung Cancer: Unlocking Precision Treatment","description":"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Biomarkers in Lung Cancer: Unlocking Precision Treatment","og_description":"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.","og_url":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/","og_site_name":"Dr. Belal Bin Asaf","article_author":"https:\/\/www.facebook.com\/Dr.BelalBinAsaf\/","article_published_time":"2025-10-09T13:01:20+00:00","article_modified_time":"2025-10-09T13:12:26+00:00","og_image":[{"width":1200,"height":630,"url":"http:\/\/localhost\/bilal\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp","type":"image\/webp"}],"author":"Dr. Belal Bin Asaf","twitter_card":"summary_large_image","twitter_creator":"@DrBelalBinAsaf","twitter_misc":{"Written by":"Dr. Belal Bin Asaf","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#article","isPartOf":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/"},"author":{"name":"Dr. Belal Bin Asaf","@id":"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/person\/f25b0c54277f74ec9c5f47d5800ac337"},"headline":"Biomarkers in Lung Cancer: Unlocking Precision Treatment","datePublished":"2025-10-09T13:01:20+00:00","dateModified":"2025-10-09T13:12:26+00:00","mainEntityOfPage":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/"},"wordCount":980,"commentCount":0,"publisher":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/#organization"},"image":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp","articleSection":["Lung Cancer"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/","url":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/","name":"Biomarkers in Lung Cancer: Unlocking Precision Treatment","isPartOf":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage"},"image":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp","datePublished":"2025-10-09T13:01:20+00:00","dateModified":"2025-10-09T13:12:26+00:00","description":"Discover how lung cancer biomarkers guide personalized treatments and targeted therapies, improving diagnosis and patient outcomes.","breadcrumb":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#primaryimage","url":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp","contentUrl":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp","width":1200,"height":630,"caption":"Biomarkers in Lung Cancer"},{"@type":"BreadcrumbList","@id":"https:\/\/drbelalbinasaf.com\/blog\/biomarkers-in-lung-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/drbelalbinasaf.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Biomarkers in Lung Cancer: Unlocking Precision Treatment"}]},{"@type":"WebSite","@id":"https:\/\/drbelalbinasaf.com\/blog\/#website","url":"https:\/\/drbelalbinasaf.com\/blog\/","name":"Dr. Belal Bin Asaf","description":"Blog","publisher":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/drbelalbinasaf.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/drbelalbinasaf.com\/blog\/#organization","name":"Dr. Belal Bin Asaf","url":"https:\/\/drbelalbinasaf.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/06\/dr-belal-bin-asaf-chest-surgeon.svg","contentUrl":"https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/06\/dr-belal-bin-asaf-chest-surgeon.svg","caption":"Dr. Belal Bin Asaf"},"image":{"@id":"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/drbelalbinasaf.com\/blog\/#\/schema\/person\/f25b0c54277f74ec9c5f47d5800ac337","name":"Dr. Belal Bin Asaf","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/472f981bacdff70aab78cab5a56f2cfdfc53f2eb9b5672896aecd80993d7e8ca?s=96&d=mm&r=g","caption":"Dr. Belal Bin Asaf"},"sameAs":["https:\/\/drbelalbinasaf.com\/blog","https:\/\/www.facebook.com\/Dr.BelalBinAsaf\/","https:\/\/www.instagram.com\/DrBelalBinAsaf\/","https:\/\/www.linkedin.com\/in\/dr-belal-bin-asaf-34682223\/","https:\/\/x.com\/DrBelalBinAsaf","https:\/\/www.youtube.com\/channel\/UCl5MoT9A1VxaVXT4lRnuc2w"],"url":"https:\/\/drbelalbinasaf.com\/blog\/author\/dr_admin\/"}]}},"blog_post_layout_featured_media_urls":{"thumbnail":["https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1-150x150.webp",150,150,true],"full":["https:\/\/drbelalbinasaf.com\/blog\/wp-content\/uploads\/2025\/10\/lung-cancer-and-black-phlegm_-causes-and-warning-signs-1.webp",1200,630,false]},"categories_names":{"4":{"name":"Lung Cancer","link":"https:\/\/drbelalbinasaf.com\/blog\/category\/lung-cancer\/"}},"tags_names":[],"comments_number":"0","_links":{"self":[{"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/posts\/2791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/comments?post=2791"}],"version-history":[{"count":2,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/posts\/2791\/revisions"}],"predecessor-version":[{"id":2793,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/posts\/2791\/revisions\/2793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/media\/2794"}],"wp:attachment":[{"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/media?parent=2791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/categories?post=2791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drbelalbinasaf.com\/blog\/wp-json\/wp\/v2\/tags?post=2791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}